ALG11-CDG: novel variant and review of the literature
Journal of Pediatric Endocrinology and Metabolism · 2023
DOI: 10.1515/jpem-2022-0480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2023. Verfasst von Ayşenur Engin Erdal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Metabolic Diseases, Children's Hospital, Ankara Bilkent City Hospital, Çankaya, Ankara, Türkiye. Hauptthemen laut MEDLINE: Asparagine, Congenital Disorders of Glycosylation. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objectives
Asparagine-dependent glycosylation 11-congenital disorders of glycosylation (ALG11-CDG) is a rare autosomal recessive N-glycosylation defect with multisystem involvement particularly neurological symptoms such as epilepsy and neuromotor developmental delay. Case presentation A 31-month-old male patient admitted to our center with complaints of axial hypotonia, drug-resistant myoclonic seizures, microcephaly and deafness. The electroencephalography (EEG) showed a burst-suppression pattern without hypsarrhythmia. Basal metabolic investigations were unremarkable. Progressive cerebral atrophy, hypomyelination and corpus callosum hypoplasia were striking features in brain MRI images taken during our follow-up. Compound heterozygous mutations of the ALG11 gene were found by whole exome sequencing (WES) analysis. It was determined that the c.476T>C mutation is a novel mutation. CDG type 1 pattern was detected with the examination of carbohydrate-deficient transferrin (CDT) by capillary zone electrophoresis.
Conclusions
In patients with a possible congenital defect of glycosylation, a screening test such as CDT analysis is suggested. To discover novel mutations in this rare disease group, expanded genetic analysis should be performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Metabolic Diseases, Children's Hospital, Ankara Bilkent City Hospital, Çankaya, Ankara, Türkiye.
- Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University Faculty of Medicine, Çankaya, Ankara, Türkiye.
- Department of Pediatric Neurology, Gazi University Faculty of Medicine, Ankara, Türkiye.
- Department of Pediatric Metabolic Diseases, Gazi University Faculty of Medicine, Ankara, Türkiye.
- Department of Pediatric Metabolic Diseases, Children's Hospital, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Department of Pediatric Metabolic Diseases, Children's Hospital, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye.
ORCID-Profile: Ayşenur Engin Erdal, Rıdvan Murat Öktem, Oya Kıreker Köylü
Zitieren
APA
Erdal, A. E., Ceylan, A. C., Gücüyener, K., Öktem, R. M., Kıreker Köylü, O., & Kasapkara, Ç. S. (2023). ALG11-CDG: novel variant and review of the literature. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2022-0480
Vancouver
Erdal AE, Ceylan AC, Gücüyener K, Öktem RM, Kıreker Köylü O, Kasapkara ÇS. ALG11-CDG: novel variant and review of the literature. Journal of Pediatric Endocrinology and Metabolism. 2023. doi:10.1515/jpem-2022-0480
BibTeX
@article{Erdal2023,
author = {Erdal, Ayşenur Engin and Ceylan, Ahmet Cevdet and Gücüyener, Kıvılcım and Öktem, Rıdvan Murat and Kıreker Köylü, Oya and Kasapkara, Çiğdem Seher},
title = {ALG11-CDG: novel variant and review of the literature},
journal = {Journal of Pediatric Endocrinology and Metabolism},
year = {2023},
doi = {10.1515/jpem-2022-0480}
}
EUVIMED